India  
 
NewsR.in

Reporter Update: Moderna's COVID-19 Vaccine Candidate Shows 94.5% Efficacy In Phase 3 Trials

Video Credit: KDKA CBS 2 Pittsburgh - Duration: 00:40s - Published
Reporter Update: Moderna's COVID-19 Vaccine Candidate Shows 94.5% Efficacy In Phase 3 Trials

Reporter Update: Moderna's COVID-19 Vaccine Candidate Shows 94.5% Efficacy In Phase 3 Trials

Moderna announced Monday that their COVID-19 vaccine candidate is showing 94.5% efficacy; KDKA's Amy Wadas reports.


You Might Like

Related news from verified sources

India in talks with Moderna for its COVID-19 vaccine candidate: Report

India is in dialogue with the US-based biotech giant Moderna over the progress in the clinical trials...
Mid-Day - Published


Related videos from verified sources

Moderna Applies For Emergency FDA Authorization After Successful Vaccine Trials [Video]

Moderna Applies For Emergency FDA Authorization After Successful Vaccine Trials

Moderna is the second company in the U.S. to release its full trial results and apply for emergency use authorization.

Credit: CBS 2 New York     Duration: 02:17Published
Moderna's COVID-19 Vaccine - What's Next And Why Masks Will Still Be Needed [Video]

Moderna's COVID-19 Vaccine - What's Next And Why Masks Will Still Be Needed

Dr. Mallika Marshall explains the FDA approval process for vaccines and why masks will still be needed next year.

Credit: WBZ CBS Boston     Duration: 01:42Published
Moderna To Send Its COVID-19 Vaccine To FDA For Emergency Use Authorization [Video]

Moderna To Send Its COVID-19 Vaccine To FDA For Emergency Use Authorization

WBZ TV's Nick Giovanni reports.

Credit: WBZ CBS Boston     Duration: 02:28Published